316 NEW ZEALAND GAZETTE No. 15

per dose form and not more than 1.2 milligrams per
recommended daily dose of total solanaceous alkaloids
Diclofenac; in solid dose form containing 12.5 milligrams or
less per dose form in packs of not more than 20 tablets
or capsules
Duboisia leichhardtii; for oral use in liquid form in
medicines containing 0.03% or less and 0.3 milligrams or
less per dose and not more than 1.2 milligrams
per recommended daily dose of total solanaceous
alkaloids or in solid dose form in medicines containing
0.3 milligrams or less per dose form and not more
than 1.2 milligrams per recommended daily dose of total
solanaceous alkaloids

Duboisia myoporides; for oral use in liquid form in
medicines containing 0.03% or less and 0.3 milligrams
or less per dose and not more than 1.2 milligrams per
recommended daily dose of total solanaceous alkaloids
or in solid dose form in medicines containing 0.3
milligrams or less per dose form and not more than
1.2 milligrams per recommended daily dose of total
solanaceous alkaloids

Fluorides; for internal use in medicines containing 2.2
milligrams or less per dose form of sodium fluoride; for
external use in medicines other than pastes, gels or
powders for cleaning the teeth containing 2.5% or less;
except in oral hygiene products other than pastes, gels or
powders for cleaning the teeth containing 0.01% or less

Flurbiprofen; in throat lozenges containing 10 milligrams or
less per lozenge

Folic acid; for oral use in medicines containing more than
500 micrograms per recommended daily dose

Folinic acid; for oral use in medicines containing more than
500 micrograms per recommended daily dose

Glyceryl trinitrate; for external use; except in medicines
containing 100 micrograms or less per litre or per
kilogram

Hyoscine; for transdermal use in medicines containing
2 milligrams or less of total solanaceous alkaloids per
dose unit; for oral use in liquid form in medicines
containing 0.03% and 0.3 milligrams or less per dose
and not more than 1.2 milligrams per recommended
daily dose or in solid dose form in medicines containing
0.3 milligrams or less per dose unit and not more
than 1.2 milligrams per recommended daily dose of total
solanaceous alkaloids

Hyoscyamine; for external use in medicines containing
0.03% or less of total solanaceous alkaloids; for oral
use in liquid form in medicines containing 0.03% and
0.3 milligrams or less per dose and not more than 1.2
milligrams per recommended daily dose or in solid dose
form in medicines containing 0.3 milligrams or less
per dose unit and not more than 1.2 milligrams per
recommended daily dose of total solanaceous alkaloids

Hyoscyamus niger; for oral use in liquid form in medicines
containing 0.03% and 0.3 milligrams or less per dose
and not more than 1.2 milligrams per recommended
daily dose of total solanaceous alkaloids or in solid dose
form in medicines containing 0.3 milligrams or less
per dose unit and not more than 1.2 milligrams per
recommended daily dose except in packs containing
30 micrograms or less of total solanaceous alkaloids

*Ibuprofen; for external use; for oral use in either
liquid form in packs containing not more than 4 grams or
in solid dose form containing not more than 200
milligrams per dose form and when in medicines
which have received the consent of the Minister or
the Director-General to their sale as pharmacy-only
medicines and which are sold in the manufacturer’s
original pack

Injectable medicines; except when specified elsewhere in
the schedule; except for Factor VIII; except for contrast
media, parenteral nutrition replacement preparations,
plasma volume expanders or intraocular viscoelastic
preparations

Lignocaine; for external use in medicines containing 10% or
less and more than 2%; for urethral use

Minoxidil; for external use in medicines containing 5% or
less

Nicotine; for inhalation except when sold from a smoking
cessation clinic run under the auspices of a registered
medical practitioner, nurse, pharmacist or psychologist

*Nizatidine; in medicines which have received the consent
of the Minister or the Director-General to their sale as
pharmacy-only medicines and which are sold in the
manufacturer’s original pack containing not more than
14 days’ supply

Nystatin; for dermal use

Podophyllum emodi; for external use for the treatment of
warts other than anogenital warts in medicines
containing 10% or less of podophyllin

Podophyllum peltatum; for external use for the treatment of
warts other than anogenital warts in medicines
containing 10% or less of podophyllin

Podophyllotoxin; for external use for the treatment of warts
other than anogenital warts in medicines containing
0.5% or less

Potassium chlorate; except in medicines containing 10% or
less

Prilocaine; for dermal use in medicines containing 10% or
less

Pyrithione zinc; for external use in medicines containing
more than 2%

Sabadilla; in packs containing 18 milligrams or less of total
alkaloids except in packs containing 1.8 milligrams or
less and a recommended daily dose of not more than 0.6
milligrams of total alkaloids

Silver; except in oral solutions containing 0.3% or less or
other medicines containing 1% or less

Silver sulfadiazine; for external use in packs containing
50 grams or less

Medicines for General Sale

Please note that the following medicines are no longer
classified as prescription medicines, restricted medicines or
pharmacy-only medicines. As such, they are now available
for general sale.

Aciclovir; for external use for the treatment of herpes
labialis in medicines containing 5% or less and tubes
containing 3 grams or less

Bamifylline
Benzamine
Benzyl benzoate
Bifonazole; for external use in medicines for tinea pedis
only or in shampoos containing 1% or less
Butyl aminobenzoate; in medicines for dermal use
containing 2% or less
Dichlofenthion
Diprophylline
Fluorides; in pastes, gels or powders for cleaning the
teeth containing 0.1% or less; in oral hygiene products
other than pastes, gels or powders for cleaning the
teeth containing 0.01% or less; in parenteral nutrition
replacement preparations; in medicines containing
15 milligrams or less per litre or per kilogram

Folic acid; for oral use in medicines containing 500
micrograms or less per recommended daily dose